AvidinOX™ for Highly Efficient Tissue-Pretargeted Radionuclide Therapy-Reference-Cited by-同舟云学术

AvidinOX™ for Highly Efficient Tissue-Pretargeted Radionuclide Therapy

Published:2010-04 Issue:2 Volume:25 Page:143-148
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

De Santis Rita¹,Leoni Barbara¹,Rosi Antonio¹,Albertoni Claudio¹,Forni Guido²,Cojoca Rodica²,Iezzi Manuela³,Musiani Piero³,Paganelli Giovanni⁴,Chinol Marco⁴,Carminati Paolo¹

Affiliation:

1. Department of Immunology, Sigma-Tau SpA R&D, Rome, Italy.

2. Turin University, Turin, Italy.

3. CeSI, G. d'Annunzio University Foundation, Chieti, Italy.

4. European Institute of Oncology, Milan, Italy.

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/cbr.2009.0738

Reference34 articles.

1. Investigation of Interfraction Variations of MammoSite Balloon Applicator in High-Dose-Rate Brachytherapy of Partial Breast Irradiation

2. Systemic iodine 125 activity after GliaSite brachytherapy: Safety considerations

3. Long-term outcome and toxicity in a Phase I/II trial using high-dose-rate multicatheter interstitial brachytherapy for T1/T2 breast cancer

4. Brachytherapy of Liver Metastases

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pretargeting: A Path Forward for Radioimmunotherapy;Journal of Nuclear Medicine;2022-09

2. Strategies to expand the therapeutic potential of superoxide dismutase by exploiting delivery approaches;International Journal of Biological Macromolecules;2021-01

3. Avidin-biotin approach for cancer therapy and new biotin derivatives;Reference Module in Biomedical Sciences;2021

4. Anti-ErbB2 immunotherapeutics: struggling to make better antibodies for cancer therapy;mAbs;2020-01-01

5. Therapeutic Applications of Pretargeting;Pharmaceutics;2019-09-01